Aurobindo Pharma arm announces successful Phase 1 clinical study outcome of their BP11 product Susmita Roy18 March 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, has announced that their Omalizumab biosimilar...
FDA approves first treatment for reactions to multiple foods after accidental exposure Dr. Kamal Kant Kohli19 Feb 2024 10:00 AM ISTThe FDA has approved omalizumab (Xolair) injection as first medication to help reduce allergic reactions to multiple foods after accidental exposure. ...
Roche Xolair gets USFDA nod for children, adults with one or more food allergies Ruchika Sharma17 Feb 2024 4:30 PM ISTIn the U.S., Genentech, a member of the Roche Group, and Novartis Pharmaceuticals Corporation work together to develop and co-promote Xolair.
Roche Xolair gets USFDA priority review for children, adults with food allergies Ruchika Sharma20 Dec 2023 12:41 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted, under Priority Review, the company's supplemental...
Novartis gets CDSCO Committee nod to Xolair to treat rhinosinusitis with nasal polyps Medical Dialogues Team17 March 2021 9:15 AM ISTNew Delhi: Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization (CDSCO) has granted permission to Novartis...
